Among adults with mood and psychotic disorders, sodium-glucose cotransporter 2 inhibitor use are associated with a lower risk for dementia.

Men hospitalized for first-episode psychosis with cannabis exposure vs no cannabis exposure showed distinct clinical and cognitive features.

Greater consumption of ultraprocessed foods in early childhood is associated with brain development by age 6 years.

Postoperative opioid prescribing for Medicaid enrollees fell substantially between 2016 and 2022 across multiple surgical procedures.

Antenatal opioid exposure is associated with reduced cerebral cortical sulcal depth and surface area in newborns, varying by ...

Researchers compared the prognostic value of clinically interpreted CT vs MRI for incidentally discovered covert cerebrovascular disease.

Emerging biomarkers and genetic profiles may help identify patients with high risk for sudden epileptic death.

Many young adults are not engaging with primary care compared with health care use patterns seen in previous generations.

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA ...

Fluoxetine, cognitive behavioral therapy, and combined therapy offer similar symptom reduction among youths with anxiety disorders.

Proposed legislation aims to improve methadone access for opioid use disorder by allowing prescriptions at community pharmacies.

Phase 3 COMP006 trial results demonstrate that COMP360, an investigational synthetic psilocybin formulation, provides a rapid and durable clinical benefit through 6 months in patients with chronic ...